A batch of Pediatrix Acetaminophen Oral Solution, a children’s liquid pain medicine from Teva Canada Ltd., is under recall due to elevated levels of acetaminophen, posing a risk of overdose. The non-prescription product is commonly used to alleviate pain and fever in children aged two to 11 years.
Health Canada has issued a warning, emphasizing the potential danger for children, who, due to their small size and developing bodies, may be more susceptible to the adverse effects of acetaminophen overdose. An overdose of this medication can lead to severe illness and, in extreme cases, death.
It’s crucial for parents to be vigilant, as the initial signs of liver damage, such as abdominal pain, may not be immediately apparent. Health Canada notes that these symptoms might take 24 to 48 hours to manifest and can ultimately result in liver failure or, in severe instances, death.
In response to this recall, parents are advised to check their medicine cabinets and discontinue the use of the affected product. If a child shows any signs or symptoms of an acetaminophen overdose, immediate contact with the local poison control centre or emergency health care services is strongly recommended.
Ensuring the safety of children is paramount, and prompt action is essential in addressing any potential risks associated with the recalled medication. Parents are urged to stay informed about the recall and take appropriate measures to safeguard the well-being of their children.
In conclusion, the recall of Pediatrix Acetaminophen Oral Solution underscores the critical importance of medication safety, particularly for children. Vigilance by parents and swift response to potential risks is crucial. Health Canada’s proactive warning serves as a reminder to prioritize children’s well-being and underscores the ongoing need for stringent pharmaceutical quality control.
